Strata Critical Medical Profit Margin

As of the most recent data (June 2026), SRTAW shows a profit margin of 18.98%. That compares with -7.46% in the prior-year period — up 354.3% year over year. That is above the Industrials sector average of 8.2%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SRTAW's profit margin is now 18.98% (was -7.46%) — a 354.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Strata Critical Medical is outperforming or lagging.

The Industrials sector average profit margin is about 8.2%. Strata Critical Medical is at 18.98%, which is higher that average. That is roughly 131.4% above the sector mean. Use the comparison chart on this page to see how SRTAW stacks up against individual peers as well.

That compares with -7.46% in the prior-year period — up 354.3% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Strata Critical Medical with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Strata Critical Medical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 18.98%) with ownership activity and broader fundamentals.